Sign Up
OverviewAPI
The sequencing kit, next generation sequencing (NGS), and NGS informatics markets are projected to experience significant growth by 2029, with the NGS market expected to reach $13.7 billion by 2030. These markets are driven by factors such as increasing cancer prevalence, technological advancements, and the rise in pharmaceutical R&D expenditure. Key players in these markets include Illumina, Thermo Fisher Scientific, Roche, and Agilent Technologies.

Ask a question